Home LiteratureArticle Details
PMID: 8892904 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

Journal of virology ·Vol. 70 ·No. 11 ·1996-11-00 ·Pages 7827-32

Weber J, Fenyö EM, Beddows S, Kaleebu P, Björndal A

Abstract

Human immunodeficiency virus type 1 (HIV-1) primary isolates from four geographical locations in Thailand, Brazil, Rwanda, and Uganda, representing genetic subtypes A, B, C, D, and E, were examined for autologous and heterologous neutralization by panels of human HIV+ polyclonal plasma. In independent linked experiments in three laboratories using diverse methodologies and common reagents, no defined pattern of genetic subtype-specific neutralization was observed. Most plasma tested were broadly cross-neutralizing across two or more genetic subtypes, although the titer of neutralization varied across a wide range. We conclude that the genetic subtypes of HIV-1 are not classical neutralization serotypes.

MeSH Terms
HIV Infections/blood,immunology,virology HIV-1/classification,immunology Humans Neutralization Tests Serotyping
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Weber J
Department of Communicable Diseases, Imperial College School of Medicine at St. Mary's, London, United Kingdom.
Fenyö E M
Beddows S
Kaleebu P
Björndal A
References (17)
17 references, click to expand
  1. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes.
    Science. 1993 Nov 19;262(5137):1257-61 PMID: 8235655
  2. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes.
    AIDS. 1993 Jun;7(6):769-80 PMID: 8363755
  3. Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.
    J Virol. 1994 Mar;68(3):1342-9 PMID: 8107199
  4. Human immunodeficiency virus type 1 quantitative cell microculture as a measure of antiviral efficacy in a multicenter clinical trial.
    J Infect Dis. 1995 Feb;171(2):305-11 PMID: 7844365
  5. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1359-68 PMID: 7888189
  6. Serotyping HIV type 1 by antibody binding to the V3 loop: relationship to viral genotype. WHO Network for HIV Isolation and Characterization.
    AIDS Res Hum Retroviruses. 1994 Nov;10(11):1379-86 PMID: 7888191
  7. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.
    AIDS. 1995 Aug;9(8):867-74 PMID: 7576320
  8. Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers.
    Vaccine. 1995 Jun;13(9):831-4 PMID: 7483805
  9. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes.
    J Virol. 1996 Jan;70(1):427-44 PMID: 8523556
  10. Quantitative analysis of serum neutralization of human immunodeficiency virus type 1 from subtypes A, B, C, D, E, F, and I: lack of direct correlation between neutralization serotypes and genetic subtypes and evidence for prevalent serum-dependent infectivity enhancement.
    J Virol. 1996 Jan;70(1):445-58 PMID: 8523557
  11. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics.
    J Med Virol. 1989 Nov;29(3):170-5 PMID: 2482339
  12. Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.
    AIDS. 1990 Feb;4(2):107-12 PMID: 2328092
  13. Statistical analysis of sparse infection data and its implications for retroviral treatment trials in primates.
    Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7581-5 PMID: 1323844
  14. Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?
    Lancet. 1992 Nov 21;340(8830):1257-8 PMID: 1359323
  15. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand.
    Lancet. 1993 May 8;341(8854):1171-4 PMID: 8098076
  16. Antigen detection is a reliable method for evaluating HIV/SIV neutralization assays.
    AIDS Res Hum Retroviruses. 1993 Jun;9(6):501-4 PMID: 8394094
  17. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype.
    J Infect Dis. 1994 Jan;169(1):48-54 PMID: 8277197
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1996-11-00
Pages
7827-32
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC190853
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]